Andrew David Siderowf, MD

Neurology
Accepting new patients
Sees patients age 18 and up
Penn Neurology Pennsylvania Hospital
Schedule onlineCall 800-789-7366
Headshot of Andrew David Siderowf, MD
Penn Medicine Provider

About me

  • Division Chief, Movement Disorders
  • Howard Hurtig, M.D.-Matthew Stern, M.D. Professor in Neurology

My education and training

  • Medical School: Duke University Medical Center
  • Residency: University of Pennsylvania Health System
  • Fellowship: Virginia Commonwealth University Nurse Anesthesia

Spoken languages

English
English

Reviews

Average Rating

396 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
wonderful experience
Anonymous
May 2026
knowledgeable and helpful
Anonymous
April 2026
he asked me for all details of my situation and provided me with valuable advices.
Anonymous
April 2026
expertise

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Siderowf is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Siderowf A, Stern MB. Update on Parkinson’s Disease. , Annals of Internal Medicine. , 138(8): 2003,651-658

Umemura A. Jaggi JL. Hurtig HI. Siderowf AD. Colcher A. Stern MB. Baltuch GH. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. , Journal of Neurosurgery , 98(4): 2003,779-784

Siderowf A, Quinn NP. Progressive supranuclear palsy: Setting the scene for clinical trials. , Neurology , 60: 2003,892-893

Siderowf AD, McDermott M, Keiburtz KD, Blindauer K, Plumb S, Shoulson I and the Parkinson Study Group. Test-retest reliability of the UPDRS: Results from a multicenter clinical trial. , Movement Disorders. , 17: 2002,758-763

Simuni T, Jaggi J, Mulholland H, Hurtig H, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH. Bilateral Stimulation of the Subthalamic Nucleus in Parkinson's Disease: A Study of Efficacy and Safety. , Journal of Neurosurgery. , 96: 2002,666-672

Gregory S, Siderowf A, Golaszewski AL, McClusky L. Gastrostomy insertion in ALS patients with low vital capacity: Respiratory support and survival. , Neurology. , 58: 2002,485-487

Siderowf AD, Ravina B. Glick HA. Preference-based quality of life in patients with Parkinson’s disease. , Neurology. , 59: 2002,103-108

Parkinson Study Group (Siderowf, A. corresponding author). A controlled trial of rasagiline in early Parkinson disease. , Archives of Neurology. , 59: 2002,1937-1943

Siderowf AD, Stern MD. Status of Neuroprotective Therapy , Parkinson’s Disease: Diagnosis and clinical management. New York. Demos Medical Publishing: 2002,481-494

Siderowf AD, Holloway RG. Economic burden of Parkinson’s disease: Implications for interventions. , Parkinson’s Disease: Diagnosis and clinical management. New York. Demos Medical Publishing: 2002,639-646